default author photo

Elisa Marchetti

GSK Vaccines Institute for Global Health

Avenue Fleming 20

Waver, 1300

Belgium

  • GSK Vaccines Institute for Global Health

SCHOLARLY PAPERS

2

DOWNLOADS

193

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Efficacy, Safety, and Immunogenicity of the Shigella sonnei 1790GAHB GMMA Candidate Vaccine: Results from a Phase 2b Randomized, Placebo-Controlled Challenge Study in Adults

Number of pages: 33 Posted: 02 Mar 2021
Robert Frenck, Valentino Conti, Pietro Ferruzzi, Augustin GW Ndiaye, Susan Parker, Monica McNeal, Michelle Dickey, Juan-Paolo Granada, Giulia Luna Cilio, Iris De Ryck, Francesca Necchi, Akamol E. Suvarnapunya, Omar Rossi, Alessandra Acquaviva, Lakshmi Chandrasekaran, Kristen A. Clarkson, Joachim Auerbach, Elisa Marchetti, Robert W. Kaminski, Francesca Micoli, Rino Rappuoli, Allan Saul, Laura B. Martin and Audino Podda
Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, GSK Vaccines Institute for Global Health, GSK, GSK, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, Fondazione Toscana Life Sciences - Monoclonal Antibody Discovery Lab (MAD), Burnet Institute, GSK Vaccines Institute for Global Health and GSK Vaccines Institute for Global Health
Downloads 122 (588,531)

Abstract:

Loading...

Shigella sonnei, 1790GAHB vaccine, GMMA, human challenge study, controlled human infection model, shigellosis

2.

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine Administered with Routine EPI Vaccines in African Infants and Toddlers

Number of pages: 41 Posted: 06 Jun 2025
Abraham Hodgson, Fadima Haidara, Samba O. Sow, Patrick Odum Ansah, Nana Akosua Ansah, Milagritos D. Tapia, Oscar Bangre, Godwin Enwere, Simonetta Viviani, Elisa Marchetti, Emanuele Montomoli, Valerio Stanzani, Yuxiao Tang, Brian Plikaytis, Varsha Parulekar, Lionel Martellet, Julie Chaumont, Marie-Françoise Makadi, Prasad S. Kulkarni, George Carlone, Ray Borrow, F. Marc LaForce and Marie-Pierre Préziosi
Ghana Health Service, Centre pour le Développement des Vaccins (CVD-Mali), Government of Mali - Centre pour le Développement des Vaccins, Navrongo Health Research Centre (NHRC), Navrongo Health Research Centre (NHRC), - Department of Pediatrics, Navrongo Health Research Centre (NHRC), World Health Organization (WHO), PATH, GSK Vaccines Institute for Global Health, University of Siena, University of Siena, PATH, U.S. Centers for Disease Control and Prevention, DiagnoSearch Life Sciences, PATH, PATH, PATH, Serum Institute of India Private Ltd, U.S. Centers for Disease Control and Prevention, Meningococcal Reference Unit, UK Health Security Agency, PATH and World Health Organization (WHO)
Downloads 71 (867,774)

Abstract:

Loading...

bacterial meningitis, meningococcal conjugate vaccine, serogroup A, African meningitis belt